Developing iPSC-derived MSC-based therapies: an interview with Ross Macdonald, Cynata Therapeutics
In this interview from the World Stem Cell Summit (22–26 January, Miami, FL, USA), Ross Macdonald discusses the advantages of MSC-based cell therapies.
Please sign in or register for FREE
Sign in to RegMedNet
Not yet a member? Become a member FREE to:
- Get unlimited access to ALL CONTENT
- Read selected articles from journals such as Regenerative Medicine FREE
- Receive a weekly email roundup of the latest news and expert opinions
Did you know?
Your RegMedNet account also gives you access to communities on drug discovery, real-world evidence and 3D printing in medicine. Find out more>>